Developing Strategies for Myelofibrosis Treatment

Aaron Gerds, MD, MS, explains the types, presentations, and classic symptoms of myelofibrosis.

An expert on hematologic malignancies discusses the prognostic factors and molecular pathways involved in myelofibrosis.

A comprehensive overview of ruxolitinib, fedratinib, and pacritinib, the approved therapies for the treatment of myelofibrosis.

Aaron Gerds, MD, MS, discusses the MOMENTUM study and the potential role of momelotinib in the myelofibrosis treatment landscape.

An expert oncologist overviews quality-of-life data and considerations in treatment sequencing in myelofibrosis.

A thorough review of promising therapies currently under investigation for the treatment of myelofibrosis.

Aaron Gerds, MD, MS, offers closing remarks on the outlook for the treatment of myelofibrosis, and shares advice for community oncologists.